BlackRock Portfolio Management LLC Increases Stake in Anika Therapeutics Inc to 4.1%

On July 17, 2026, BlackRock Portfolio Management LLC filed a Schedule 13G/A with the SEC, disclosing a position in Anika Therapeutics Inc (ANIK). According to the filing, the reporting person beneficially owns 544,710 shares of common stock, representing a 4.1% ownership stake in the company. The event date for this disclosure was June 30, 2026. The filing indicates that BlackRock Portfolio Management LLC has sole voting power over 520,622 shares and sole dispositive power over the full 544,710 shares. This filing is an amendment (Amendment No. 1) to a previous disclosure. Notably, the current ownership level has fallen below the 5% threshold, as indicated by the checkbox in Item 5. The shares were acquired in the ordinary course of business and not for the purpose of influencing or changing control of the issuer. Various persons associated with the reporting entity have the right to receive dividends or proceeds from the sale of these securities, though no single person's interest exceeds 5% of the total outstanding shares.